益生菌衍生后生物:对下一代治疗方法的视角
Veilumuthu Pattapulavar1, Sathiyabama Ramanujam2, Bhagyashree Kini1
1Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.
Frontiers in nutrition
|August 1, 2025
概括
后生物质,有益的微生物代谢产物,为肠道健康提供了益生菌有前途,稳定的替代品. 它们通过支持免疫力和新陈代谢来管理各种健康状况.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 代谢科学 代谢科学
背景情况:
- 肠道微生物组对宿主健康至关重要,而肠道功能失调与癌症和IBD等疾病有关.
- 益生菌用于微生物平衡,但面临着不一致的殖民和基因转移等挑战.
- 后生物质,即不可活的微生物代谢物,正在成为一种更安全,更有效的替代品.
研究的目的:
- 审查关于后生菌作为益生菌的治疗替代品的文献.
- 总结关键后生物类的特性和应用.
- 讨论后生物制剂的进展和未来的研究方向.
主要方法:
- 文献综述专注于后生菌及其治疗潜力.
- 对外聚糖,无细胞超,短链脂肪酸和细菌素的分析.
- 检查配方技术,如封装以提高稳定性.
主要成果:
- 后生物体表现出免疫调节,抗菌,抗氧化和抗癌作用.
- 封装等配方策略可以提高后生物稳定性和生物可用性.
- 关键的后生物类包括外聚糖,SCFA和细菌素.
结论:
- 后生物体是一种可持续的,非可行的,功能丰富的治疗选择.
- 需要进一步的研究来规范成分,澄清机制,并评估安全性.
- 后生物质与全球健康目标保持一致,以获得更安全,更可扩展的健康解决方案.
相关概念视频
Microorganisms in Medicine and Therapeutics
345
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
345
Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193
Drugs for Treatment of Diarrhea-Predominant IBS
299
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
299
Drugs for Treatment of Constipation-Predominant IBS
336
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
336
Prodrugs
2.9K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.9K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
319
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
319


